Pfizer

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
1.1	Statement from the most senior decision-maker of the organization (e.g., CEO, chair, or equivalent senior position) about the relevance of sustainability to the organization and its strategy.		CEO Letter
1.2	Description of key impacts, risks, and opportunities.		New Era of Responsibility Public Policy Research & Development Access to Medicines Patient Safety Environment, Health, and Safety		8

Covered

Partially Covered

Not Covered

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
2.1	Name of the organization.		Pfizer Company Profile
2.2	Primary brands, products, and/or services.		Pfizer Company Profile Research & Development
2.3	Operational structure of the organization, including main divisions, operating companies, subsidiaries, and joint ventures.		Pfizer Company Profile; 10-K
2.4	Location of organization's headquarters.		Pfizer Company Profile
2.5	Number of countries where the organization operates, and names of countries with either major operations or that are specifically relevant to the sustainability issues covered in the report.		Pfizer Company Profile; 10-K
2.6	Nature of ownership and legal form.		Pfizer Company Profile
2.7	Markets served (including geographic breakdown, sectors served, and types of customers/beneficiaries).		Pfizer Company Profile
2.8	Scale of the reporting organization		Pfizer Company Profile; 10-K
2.9	Significant changes during the reporting period regarding size, structure, or ownership		CEO Letter; www.pfizer.com
2.10	Awards received in the reporting period.		Accolades

Covered

Partially Covered

Not Covered

Report Profile

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
3.1	Reporting period (e.g., fiscal/calendar year) for information provided.		About the Report
3.2	Date of most recent previous report (if any).		About the Report
3.3	Reporting cycle (annual, biennial, etc.)		About the Report
3.4	Contact point for questions regarding the report or its contents.		About the Report

Report Scope and Boundary

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
3.5	Process for defining report content.		About the Report Stakeholder Engagement
3.6	Boundary of the report (e.g., countries, divisions, subsidiaries, leased facilities, joint ventures, suppliers). See GRI Boundary Protocol for further guidance.		About the Report
3.7	State any specific limitations on the scope or boundary of the report.		N/A
3.8	Basis for reporting on joint ventures, subsidiaries, leased facilities, outsourced operations, and other entities that can significantly affect comparability from period to period and/or between organizations.		About the Report
3.9	Data measurement techniques and the bases of calculations, including assumptions and techniques underlying estimations applied to the compilation of the Indicators and other information in the report.		Environment, Health and Safety
3.10	Explanation of the effect of any re-statements of information provided in earlier reports, and the reasons for such re-statement (e.g., mergers/acquisitions, change of base years/periods, nature of business, measurement methods).		N/A
3.11	Significant changes from previous reporting periods in the scope, boundary, or measurement methods applied in the report.		N/A

GRI Content Index

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
3.12	Table identifying the location of the Standard Disclosures in the report.		About the Report

Assurance

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
3.13	Policy and current practice with regard to seeking external assurance for the report. If not included in the assurance report accompanying the sustainability report, explain the scope and basis of any external assurance provided. Also explain the relationship between the reporting organization and the assurance provider(s).		N/A

Covered

Partially Covered

Not Covered

GOVERNANCE

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
4.1	Governance structure of the organization, including committees under the highest governance body responsible for specific tasks, such as setting strategy or organizational oversight.		Pfizer Company Profile Board Governance
4.2	Indicate whether the Chair of the highest governance body is also an executive officer (and, if so, their function within the organization's management and the reasons for this arrangement).		Governance
4.3	For organizations that have a unitary board structure, state the number of members of the highest governance body that are independent and/or non- executive members.		Pfizer Company Profile Board Governance; Proxy Statement
4.4	Mechanisms for shareholders and employees to provide recommendations or direction to the highest governance body.		Pfizer website
4.5	Linkage between compensation for members of the highest governance body, senior managers, and executives (including departure arrangements), and the organization's performance (including social and environmental performance).		Executive Compensation
4.6	Processes in place for the highest governance body to ensure conflicts of interest are avoided.		Ethics & Compliance
4.7	Process for determining the qualifications and expertise of the members of the highest governance body for guiding the organization's strategy on economic, environmental, and social topics.		Board Governance
4.8	Internally developed statements of mission or values, codes of conduct, and principles relevant to economic, environmental, and social performance and the status of their implementation.		Clinical Trials Stem Cells Animal Care and Use Ethical Marketing Interactions with Healthcare Professionals Board Governance Ethics & Compliance Lobbying & Political Contributions
4.9	Procedures of the highest governance body for overseeing the organization's identification and management of economic, environmental, and social performance, including relevant risks and opportunities, and adherence or compliance with internationally agreed standards, codes of conduct, and principles.		Pfizer Corporate Responsibility Board Governance
4.10	Processes for evaluating the highest governance body's own performance, particularly with respect to economic, environmental, and social performance.		Board Governance

COMMITMENTS TO EXTERNAL INITIATIVES

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
4.11	Explanation of whether and how the precautionary approach or principle is addressed by the organization.		Direct to Consumer Advertising Climate Change Product Stewardship		7
4.12	Externally developed economic, environmental, and social charters, principles, or other initiatives to which the organization subscribes or endorses.		Clinical Trials Ethical Marketing Interactions with Healthcare Professionals Direct to Consumer Advertising Human Rights Assessment and Improvement of EHS and Labor Practices at Key Suppliers
4.13	Memberships in associations (such as industry associations) and/or national/international advocacy organizations in which the organization		Global EHS Partnerships

STAKEHOLDER ENGAGEMENT

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
4.14	List of stakeholder groups engaged by the organization.		Stakeholder Engagement
4.15	Basis for identification and selection of stakeholders with whom to engage.		About the Report Stakeholder Engagement
4.16	Approaches to stakeholder engagement, including frequency of engagement by type and by stakeholder group.		Stakeholder Engagement
4.17	Key topics and concerns that have been raised through stakeholder engagement, and how the organization has responded to those key topics and concerns, including through its reporting.		Stakeholder Engagement Research & Development Access to Medicines Patient Safety Environment, Health & Safety Governance Supply Chain Employees & Community

Covered

Partially Covered

Not Covered

Economic Disclosures

Disclosure on Management Approach (Economy)

Economic Performance Indicators

Environmental Disclosures

Disclosure on Management Approach (Environment)

Environmental Performance Indicators

Social Disclosures

Labor Practices and Decent Work

Disclosure on Management Approach (Labor Practices and Decent Work)

Labor Practices and Decent Work Performance Indicators

Human Rights

Disclosure on Management Approach (Human Rights)

Human Rights Performance Indicators

Society

Disclosure on Management Approach (Society)

Society Performance Indicators

Product Responsibility

Disclosure on Management Approach (Product Responsibility)

Product Responsibility Performance Indicators

Covered

Partially Covered

Not Covered